Literature DB >> 21615633

Evaluation of the antibiotic biosynthetic potential of the genus Amycolatopsis and description of Amycolatopsis circi sp. nov., Amycolatopsis equina sp. nov. and Amycolatopsis hippodromi sp. nov.

G J Everest1, P R Meyers.   

Abstract

AIMS: To describe three new Amycolatopsis strains and assess the antibiotic biosynthetic potential of the genus. METHODS AND
RESULTS: Three strains, designated S1·3(T) , S3·6(T) and SE(8)3(T) , belonging to the genus Amycolatopsis were isolated and found to cluster together by 16S rRNA and gyrB gene-based phylogenetic analysis. Genetic distance values, based on the gyrB gene, were calculated between the strains and their closest relatives and were all above the threshold value of 0·02 that has been proposed to distinguish Amycolatopsis type strains. DNA-DNA hybridization experiments against related type strains confirmed that strain S3·6(T) represents a unique genomic species. Strain S3·6(T) was also found to be distinct from strains S1·3(T) and SE(8)3(T) , the latter two of which were also shown to be distinct from each other. Antibiotic biosynthetic genes were identified from multiple Amycolatopsis strains, and their presence was found to be phylogenetically associated.
CONCLUSIONS: The data presented in this study indicate that strains S1·3(T) , SE(8)3(T) and S3·6(T) belong to three novel species, for which the names Amycolatopsis circi sp. nov. (= DSM 45561(T) = NRRL B-24841(T) ), Amycolatopsis equina sp. nov. (= DSM 45563(T) = NRRL B-24842(T) ) and Amycolatopsis hippodromi sp. nov. (= DSM 45562(T) = NRRL B-24843(T) ) are proposed. SIGNIFICANCE AND IMPACT OF THE STUDY: Three new species of Amycolatopsis are described, and the knowledge of the antibiotic biosynthetic potential of the genus has been extended.
© 2011 The Authors. Journal of Applied Microbiology © 2011 The Society for Applied Microbiology.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21615633     DOI: 10.1111/j.1365-2672.2011.05058.x

Source DB:  PubMed          Journal:  J Appl Microbiol        ISSN: 1364-5072            Impact factor:   3.772


  6 in total

Review 1.  Advances in microbial culturing conditions to activate silent biosynthetic gene clusters for novel metabolite production.

Authors:  Hailey A Tomm; Lorena Ucciferri; Avena C Ross
Journal:  J Ind Microbiol Biotechnol       Date:  2019-06-08       Impact factor: 3.346

2.  Genetics and Genomics of the Genus Amycolatopsis.

Authors:  Rashmi Kumari; Priya Singh; Rup Lal
Journal:  Indian J Microbiol       Date:  2016-05-02       Impact factor: 2.461

3.  Overproduction of Ristomycin A by activation of a silent gene cluster in Amycolatopsis japonicum MG417-CF17.

Authors:  Marius Spohn; Norbert Kirchner; Andreas Kulik; Angelika Jochim; Felix Wolf; Patrick Muenzer; Oliver Borst; Harald Gross; Wolfgang Wohlleben; Evi Stegmann
Journal:  Antimicrob Agents Chemother       Date:  2014-08-11       Impact factor: 5.191

4.  Comparative Genomics and Biosynthetic Potential Analysis of Two Lichen-Isolated Amycolatopsis Strains.

Authors:  Marina Sánchez-Hidalgo; Ignacio González; Cristian Díaz-Muñoz; Germán Martínez; Olga Genilloud
Journal:  Front Microbiol       Date:  2018-03-13       Impact factor: 5.640

5.  A genetics-free method for high-throughput discovery of cryptic microbial metabolites.

Authors:  Fei Xu; Yihan Wu; Chen Zhang; Katherine M Davis; Kyuho Moon; Leah B Bushin; Mohammad R Seyedsayamdost
Journal:  Nat Chem Biol       Date:  2019-01-07       Impact factor: 15.040

6.  Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism.

Authors:  James Peek; Mirjana Lilic; Daniel Montiel; Aleksandr Milshteyn; Ian Woodworth; John B Biggins; Melinda A Ternei; Paula Y Calle; Michael Danziger; Thulasi Warrier; Kohta Saito; Nathaniel Braffman; Allison Fay; Michael S Glickman; Seth A Darst; Elizabeth A Campbell; Sean F Brady
Journal:  Nat Commun       Date:  2018-10-08       Impact factor: 14.919

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.